The Differential Diagnosis of Prostatic Carcinoma:Its Distinction from Premalignant and Pseudocarcinomatous Lesions of the Prostate Gland
Edward C. Jones, Robert H. Young
Abstract
Edward C. Jones, Robert H. Young
Abstract
Prostate gland specimens account for a significant percentage of diagnostically challenging cases in surgical pathology practice. The understanding of prostate pathology has progressed, and the differential diagnosis of prostatic carcinoma has expanded to include possible premalignant lesions and several recently described pseudocarcinomatous lesions. The authors discuss the histopathology of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia, review the evidence for their role as premalignant lesions, and discuss the criteria that allow for their distinction from prostatic adenocarcinoma. Pseudocarcinomatous lesions that must be recognized when assessing prostatic tissue include sclerosing adenosis, cribriform hyperplasia, mesonephric hyperplasia, and basal cell hyperplasia. The pathologic features and diagnostic challenges of these and other pseudocarcinomatous lesions are reviewed.
OpenAlex reports 45 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Prostate gland specimens account for a significant percentage of diagnostically challenging cases in surgical pathology practice. The understanding of prostate pathology has progressed, and the differential diagnosis of prostatic carcinoma has expanded to include possible premalignant lesions and several recently described pseudocarcinomatous lesions. The authors discuss the histopathology of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia, review the evidence for their role as premalignant lesions, and discuss the criteria that allow for their distinction from prostatic adenocarcinoma. Pseudocarcinomatous lesions that must be recognized when assessing prostatic tissue include sclerosing adenosis, cribriform hyperplasia, mesonephric hyperplasia, and basal cell hyperplasia. The pathologic features and diagnostic challenges of these and other pseudocarcinomatous lesions are reviewed.
Key concepts: Atypical adenomatous hyperplasia, Hyperplasia, Intraepithelial neoplasia, Pathology, Medicine, Prostate, Differential diagnosis, Carcinoma